The U.S. medical device testing market size was estimated at USD 3.25 billion in 2025 and is predicted to reach around USD 7.48 billion by 2035, expanding at a CAGR of 8.70% from 2026 to 2035. Innovative healthcare solutions and stringent regulatory requirements are boosting the market.

U.S. Medical Device Testing Market Statical Scope

The U.S. medical device testing market is also witnessing significant growth, driven by increasing demand for innovative healthcare solutions, stringent regulatory requirements, and a heightened focus on patient safety.

Current market conditions reflect a shift towards advanced technologies, including artificial intelligence and automation in testing procedures, which enhance the efficiency and accuracy of device assessments. Future growth prospects are optimistic, as an aging population and a rise in chronic diseases drive the demand for advanced medical devices .

U.S. Medical Device Testing Market Share, By Service Type, 2025 (%)

• Biocompatibility tests - Biocompatibility tests dominate the market, with a share of 45%, driven by stringent regulatory requirements and the need to ensure safety and compatibility of medical devices with human tissues.
• Microbiology & sterility tests - Microbiology & sterility tests hold a share of 22% of the market, supported by increasing emphasis on contamination control and infection prevention.
• Chemistry tests - Chemistry tests account for 20% of the market, driven by demand for material characterization and chemical analysis to meet regulatory standards.
• Package validation - Package validation represents 13% of the market, supported by the need to ensure packaging integrity and product stability.

U.S. Medical Device Testing Market Share, By Phase Type, 2025 (%)

• Clinical - Clinical phase dominates the market, with a share of 42%, driven by extensive testing requirements for regulatory approval and validation in human subjects.
• Preclinical - Preclinical testing accounts for 19% of the market, driven by early -stage safety and performance validation.
• Large animal research - Large animal research holds a significant share of 23% of the market, supported by the need for advanced biological evaluation prior to human trials.
• Small animal research - Small animal research represents 16% of the market, supported by cost -effective initial testing.

Top Comoanies in the U.S. Medical Device Testing Market

• WuXi AppTec
• Intertek Group Plc
• Pace Analytical Services LLC
• Eurofins Scientific
• North America Science Associates Inc. (NAMSA)
• Element Minnetonka
• Charles River Laboratories
• TÜV SÜD
• Nelson Laboratories, LLC
• Laboratory Corporation of America Holdings (Labcorp)
• SGS SA

Segments Covered in the Report

By Service Type

• Biocompatibility Tests
  
  • Cardiovascular Device's Biocompatibility Tests
  • Orthopedic Device's Biocompatibility Tests
  • Dental Implant Devices Biocompatibility Tests
  • Dermal Filler's Biocompatibility Tests
  • General Surgery Implantation Devices Biocompatibility Tests
  • Neurosurgical Implantation Devices Biocompatibility Tests
  • Ophthalmic Implantation Device's Biocompatibility Tests
  • Others
• Chemistry Tests
  
  • Chemical characterization (E&L)
  • Analytical method development and validation
  • Toxicological Risk Assessment and consulting
• Microbiology & Sterility Test
  • Bioburden Determination
  • Pyrogen & Endotoxin Testing
  • Sterility Test & Validation
  • Antimicrobial Testing
  • Others
• Package Validation

By Phase Type

• Preclinical
• Large animal research
  
  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Test
• Small animal research
  
  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Test
• Clinical